A detailed history of Capital Asset Advisory Services LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 18,448 shares of ABBV stock, worth $3.39 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
18,448
Previous 17,975 2.63%
Holding current value
$3.39 Million
Previous $3.55 Million 7.64%
% of portfolio
0.16%
Previous 0.18%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$164.99 - $203.87 $78,040 - $96,430
473 Added 2.63%
18,448 $3.28 Million
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $66,191 - $80,529
404 Added 2.3%
17,975 $3.55 Million
Q2 2024

Jul 24, 2024

SELL
$154.79 - $180.76 $174,912 - $204,258
-1,130 Reduced 6.04%
17,571 $3.01 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $177,080 - $201,766
1,108 Added 6.3%
18,701 $3.41 Million
Q4 2023

Jan 09, 2024

BUY
$137.6 - $154.97 $151,360 - $170,467
1,100 Added 6.67%
17,593 $2.73 Million
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $277,867 - $321,672
2,080 Added 14.43%
16,493 $2.46 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $90,901 - $113,121
686 Added 5.0%
14,413 $1.94 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $152,852 - $176,032
1,057 Added 8.34%
13,727 $2.19 Million
Q4 2022

Mar 08, 2023

BUY
$138.31 - $165.87 $201,241 - $241,340
1,455 Added 12.97%
12,670 $2.05 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $126,962 - $145,617
946 Added 9.21%
11,215 $1.51 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $2,890 - $3,674
21 Added 0.2%
10,269 $1.57 Million
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $413,361 - $512,865
-3,132 Reduced 23.41%
10,248 $1.66 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $69,829 - $88,354
650 Added 5.11%
13,380 $1.81 Million
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $25,748 - $29,228
242 Added 1.94%
12,730 $1.37 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $91,532 - $101,972
-870 Reduced 6.51%
12,488 $1.41 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $261,478 - $287,856
2,556 Added 23.66%
13,358 $1.45 Million
Q4 2020

Mar 02, 2021

BUY
$80.49 - $108.67 $154,057 - $207,994
1,914 Added 21.53%
10,802 $1.16 Million
Q3 2020

Nov 18, 2020

SELL
$85.91 - $100.83 $58,332 - $68,463
-679 Reduced 7.1%
8,888 $778,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $18,049 - $24,152
246 Added 2.64%
9,567 $898,000
Q1 2020

May 18, 2020

BUY
$64.5 - $97.79 $125,710 - $190,592
1,949 Added 26.44%
9,321 $838,000
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $531,165 - $664,601
7,364 Added 92050.0%
7,372 $716,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $577 - $722
8 New
8 $600,000
Q2 2018

Jul 11, 2018

SELL
$89.78 - $106.23 $230,195 - $272,373
-2,564 Closed
0 $0
Q1 2018

May 16, 2018

BUY
$92.01 - $123.21 $41,772 - $55,937
454 Added 21.52%
2,564 $243,000
Q4 2017

Jan 11, 2018

BUY
$89.56 - $98.21 $188,971 - $207,223
2,110
2,110 $204,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.